Source: PR NEWSWIRE

Press Release: Cadence Pharmaceuticals : Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc.

NEW YORK, Feb. 19, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Cadence Pharmaceuticals, Inc. ("CADX") to Mallinckrodt plc in a cash transaction...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Theodore Schroeder's photo - President & CEO of Cadence Pharmaceuticals

President & CEO

Theodore Schroeder

CEO Approval Rating

91/100

Read more